Skip to main navigation
Investor Relations
Company StatementsMedia ContactEmail Alerts
Events & PresentationsFinancialsStock InformationGovernanceResources
PatientsTeamCommunityEnvironmentCompliance & Transparency
Our LocationsMedical Information
magnifying glass icon
Incyte Home
Main Nav
  • Our Company
  • What We Do
  • Culture & Careers
  • Patient Resources
  • HCP Resources
  • Our Stories
  • Responsibility
  • Our Company
    • Our Leadership
  • What We Do
    • Portfolio
    • Oncology
      • Approved Therapies
      • HCP Resources
    • Dermatology
      • Approved Therapies
      • HCP Resources
    • Partnerships
  • Culture & Careers
    • Open Positions
    • Incyte Involved
    • Inclusion
  • Patient Resources
  • HCP Resources
  • Our Stories
  • Responsibility
    • Patients
    • Team
    • Community
    • Environment
    • Compliance & Transparency
Main Nav
  • magnifying glass icon
  • Our Company
    • magnifying glass icon
    • Our Leadership
  • What We Do
    • magnifying glass icon
    • Portfolio
    • Oncology
    • Dermatology
    • Partnerships
  • Culture & Careers
    • magnifying glass icon
    • Open Positions
    • Incyte Involved
    • Inclusion
  • Patient Resources
  • HCP Resources
  • Our Stories
  • News
    • magnifying glass icon
    • Company Statements
    • Media Contact
    • Email Alerts
  • Investors
    • magnifying glass icon
    • Events & Presentations
    • Financials
    • Stock Information
    • Governance
    • Resources
  • Responsibility
    • magnifying glass icon
    • Patients
    • Team
    • Community
    • Environment
    • Compliance & Transparency
  • Contact Us
    • magnifying glass icon
    • Our Locations
    • Medical Information
  • United States
Home  >  Investors  >  Corporate Governance

Incyte International Locations

NORTH AMERICA— HEADQUARTERS

DENMARK

ITALY

SPAIN

UNITED KINGDOM

EUROPE— HEADQUARTERS

FINLAND

JAPAN

SWEDEN

AUSTRIA

FRANCE

THE NETHERLANDS

SWITZERLAND

CANADA

GERMANY

NORWAY

PORTUGAL

Close

Corporate Governance

Committee Charters

Audit & Finance Committee

(opens in new window)

Compensation Committee

(opens in new window)

Nominating & Corporate Governance Committee

(opens in new window)

Science and Technology Committee

(opens in new window)

Committee Assignments

Audit & Finance Committee Compensation Committee Nominating and Corporate Governance Committee Science and Technology Committee
Julian C. Baker Compensation Committee Nominating and Corporate Governance Committee
Jean-Jacques Bienaimé Compensation Committee Nominating and Corporate Governance Committee
Otis W. Brawley, MD Science and Technology Committee
Paul J. Clancy Audit & Finance Committee Compensation Committee
Jacqualyn A, Fouse, PhD Audit & Finance Committee Nominating and Corporate Governance Committee
Edmund P. Harrigan, MD Audit & Finance Committee Science and Technology Committee
Katherine A. High, MD Science and Technology Committee
= Chairperson = Member = Financial Expert

Governance Documents

Corporate Governance Guidelines

(opens in new window)

Code of Business Conduct and Ethics

(opens in new window)

Senior Financial Officers’ Code of Ethics

(opens in new window)

Board of Directors Code of Conduct and Ethics

(opens in new window)

Compliance Documents

Policy on Compassionate Use

(opens in new window)

Declaration of Compliance for CA

(opens in new window)

Compliance Program for CA

(opens in new window)

Investor Contacts

Christine Chiou

Head of Investor Relations

302.274.4773

cchiou@incyte.com

Greg Shertzer, PharmD

Associate Director, Investor Relations

302.274.4779

gshertzer@incyte.com

Incyte Home © 2012-2023 Incyte.
  • Facebook Icon
  • LinkedIn Icon
  • Twitter Icon
  • Youtube Icon
  • Legal Notice
  • Privacy Policy
  • Cookie Policy
  • Site Map